|
 |
|
|||||||
|
|||||||||
Diabetes 51:1729-1736, 2002
© 2002 by the American Diabetes Association, Inc.
Central Leptin Gene Therapy Blocks High-Fat Diet-Induced Weight Gain, Hyperleptinemia, and Hyperinsulinemia
Increase in Serum Ghrelin Levels
1 Department of Physiology and Functional Genomics, University of Florida McKnight Brain Institute, College of Medicine, Gainesville, Florida
2 Department of Neuroscience, University of Florida McKnight Brain Institute, College of Medicine, Gainesville, Florida
Recombinant adeno-associated virus (rAAV), encoding either rat leptin (rAAV-lep) or green fluorescent protein (rAAV-GFP, control), was injected intracerebroventricularly in rats consuming a high-fat diet (HFD; 45 kcal%). Caloric consumption and body weight were monitored weekly until the rats were killed at 9 weeks. Untreated control rats consuming regular rat diet (RCD; 11 kcal%) were monitored in parallel. Body weight gain was accelerated in rAAV-GFP + HFD control rats relative to those consuming RCD, despite equivalent kcal consumption. At 9 weeks, serum leptin, free fatty acids, triglycerides, and insulin were elevated in HFD control rats. In contrast, rAAV-lep treatment reduced intake and blocked the HFD-induced increase in weight, adiposity, and metabolic variables. Blood glucose was slightly reduced but within the normal range, and serum ghrelin levels were significantly elevated in rAAV-lep + HFD rats. Uncoupling protein-1 (UCP1) mRNA in brown adipose tissue (BAT), an index of energy expenditure through nonshivering thermogenesis, was decreased in rats consuming HFD. Treatment with rAAV-lep significantly augmented BAT UCP1 mRNA expression, indicating increased thermogenic energy expenditure. These findings demonstrate that central leptin gene therapy efficiently prevents weight gain, increased adiposity, and hyperinsulinemia in rats consuming an HFD by decreasing energy intake and increasing thermogenic energy expenditure.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. F. Wiater, B. D. Hudson, Y. Virgin, and S. Ritter Protein appetite is increased after central leptin-induced fat depletion Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1468 - R1473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Kalra, N. Ueno, and P. S. Kalra Stimulation of Appetite by Ghrelin Is Regulated by Leptin Restraint: Peripheral and Central Sites of Action J. Nutr., May 1, 2005; 135(5): 1331 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ueno, M. G. Dube, A. Inui, P. S. Kalra, and S. P. Kalra Leptin Modulates Orexigenic Effects of Ghrelin and Attenuates Adiponectin and Insulin Levels and Selectively the Dark-Phase Feeding as Revealed by Central Leptin Gene Therapy Endocrinology, September 1, 2004; 145(9): 4176 - 4184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. INUI, A. ASAKAWA, C. Y. BOWERS, G. MANTOVANI, A. LAVIANO, M. M. MEGUID, and M. FUJIMIYA Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ FASEB J, March 1, 2004; 18(3): 439 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Chan, J. Bullen, J. H. Lee, N. Yiannakouris, and C. S. Mantzoros Ghrelin Levels Are Not Regulated by Recombinant Leptin Administration and/or Three Days of Fasting in Healthy Subjects J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 335 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. CANNON and J. NEDERGAARD Brown Adipose Tissue: Function and Physiological Significance Physiol Rev, January 1, 2004; 84(1): 277 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wilsey, S. Zolotukhin, V. Prima, and P. J. Scarpace Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1011 - R1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Duan, Z. Guo, H. Jiang, M. Ware, and M. P. Mattson Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor Endocrinology, June 1, 2003; 144(6): 2446 - 2453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bagnasco, M. G. Dube, P. S. Kalra, and S. P. Kalra Evidence for the Existence of Distinct Central Appetite, Energy Expenditure, and Ghrelin Stimulation Pathways as Revealed by Hypothalamic Site-Specific Leptin Gene Therapy Endocrinology, November 1, 2002; 143(11): 4409 - 4421. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |